University of Rome Tor Vergata-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial

    Leukemia, Vol. 38, Núm. 10, pp. 2162-2170